Access Bio Inc Cash Flow Reinvestment Rate
Access Bio Inc cash flow reinvestment rate. Access Bio Inc (950130) has a Cash Flow Reinvestment Rate of 1548.52x as of March 2025, reinvesting ₩8.29 Billion (capex ₩635.11K plus investments ₩8.29 Billion) from operating cash flow of ₩5.35 Million. See how financially flexible is Access Bio Inc to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Access Bio Inc (2012–2024)
Cash flow reinvestment rate of Access Bio Inc from 2012 to 2024. Historical reinvestment intensity for Access Bio Inc across 8 annual periods. Explore Access Bio Inc (950130) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Access Bio Inc Cash Flow Reinvestment Rate by Year (2012–2024)
Access Bio Inc cash flow reinvestment rate by year from 2012 to 2024. Year-by-year capital reinvestment analysis for Access Bio Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Access Bio Inc.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1290.23x | ₩17.47 Billion | ₩13.54 Million | ₩1.40 Million | ▲ +895.2% |
| 2022 | 129.64x | ₩37.77 Billion | ₩291.33 Million | ₩14.90 Million | ▼ -48.9% |
| 2021 | 253.51x | ₩34.96 Billion | ₩137.90 Million | ₩28.76 Million | ▲ +85255.3% |
| 2020 | 0.30x | ₩10.91 Billion | ₩36.72 Billion | ₩10.38 Billion | ▼ -93.7% |
| 2016 | 4.74x | ₩10.03 Million | ₩2.11 Million | ₩10.03 Million | ▲ +180.1% |
| 2015 | 1.69x | ₩4.85 Billion | ₩2.87 Billion | ₩4.85 Billion | ▲ +2.0% |
| 2013 | 1.66x | ₩2.63 Billion | ₩1.59 Billion | ₩2.63 Billion | ▲ +134.3% |
| 2012 | 0.71x | ₩1.31 Billion | ₩1.85 Billion | ₩1.31 Billion | — |